Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-08-18

FDA Approved: BRINZOLAMIDE — Original Application (Oceanside Pharmaceuticals.)

View source ↗

Summary

FDA approved the original application for brinzolamide from Oceanside Pharmaceuticals, establishing a generic version of the ophthalmic drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Brinzolamide (Brinzolamide)

Snippet

ORIG AP for BRINZOLAMIDE (BRINZOLAMIDE)